Expression of the co-stimulatory molecule CD40 on melanoma cells

International Journal of Cancer

Volumn 68, Issue 6, 1996, Pages 795-801

  Thomas, Wayne D ^a   Smith, Melanie J ^a   Si, Zhaoyi ^a   Hersey, Peter ^a  

^a ROYAL NEWCASTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030499377     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19961211)68:6<795::aid-ijc18>3.0.co;2-%23     Document Type: Article

References (26)

1. ALDERSON, M.R., ARMITAGE, R.J., TOUGH, T.W., STROCKBINE, L., FANSLOW, W.C. and SPRIGGS, M.K., CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. exp. Med., 178, 669-674 (1993).
2. ANICHINI, A., MORTARINI, R., ALBERTI, S., MANTOVANI, A. and PARMIANI, G., T-cell-receptor engagement and tumor ICAM-1 upregulation are required to bypass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int. J. Cancer, 53, 994-1001 (1993).
3. BANCHEREAU, J., BAZAN, F., BLANCHARD, D., BRIÉRE, F., GALIZZI, J.P., VAN KOOTEN, C., LIU, Y.J., ROUSSET, S. and SAELAND, S., The CD40 antigen and its ligand. Ann. Rev. Immunol., 12, 881-992 (1994).
4. BURDIN, B., PERONNE, C., BANCHEREAU, J. and ROUSSET, F., EpsteinBarr virus-transformation induces B lymphocytes to produce interleukin-10. J. exp. Med., 177, 295-304 (1990).
5. + T lymphocytes. J. Immunol., 152, 1523-1531 (1994).
6. + T-cell clones from regional lymph nodes of melanoma patients. Int. J. Cancer, 51, 1-7 (1992).
7. CLARK, E.A. and SHU, G., Association between IL-6 and CD40 signaling IL-6 induces phosphorylation of CD40 receptors. J. Immunol., 145, 1400-1406 (1990).
8. DAMLE, N.K., KLUSSMAN, K., LEYTZE, G., OCHS, H.D., ARUFFO, A., LINSLEY, P.S. and LEDBETTER, J.A., Co-stimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor. Cell. Immunol., 148, 144-156 (1993).
9. FREUNDENTHAL, P.S. and STEINMAN, R.M., The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. nat. Acad. Sci. (Wash.), 87, 7698-7702, (1990).
10. FUNAKOSHI, S., LONGO, D.L., BECKWITH, M., CONLEY, D.K., TSARFATY, G., TSARFATY, I., ARMITAGE, R.J., FANSLOW, W.C., SPRIGGS, M.K. and MURPHY, W.J., Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood, 83, 2787-2794 (1994).
11. GALY, A.M.M. and SPITS, H., CD40 is functionally expressed on human thymic epithelial cells. J. Immunol., 149, 775-782 (1992).
12. GIMMI, C.D., FREEMAN, G.J., GRIBBEN, J.G., GRAY, G. and NADLER, L.M., Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 co-stimulation. Proc. nat. Acad. Sci. (Wash.), 90, 6586-6590 (1993).
13. HERSEY, P., MURRAY, E., GRACE, J. and MCCARTHY, W.H., Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma. Pathology, 17, 385-391 (1985).
14. HERSEY, P., SI, Z., SMITH, M.J. and THOMAS, W.D., Expression of the co-stimulatory molecule B7 on melanoma cells. Int. J. Cancer, 58, 527-532 (1994).
15. HUTCHINS, D. and STEEL, C.M., Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer, 58, 80-84 (1994).
16. JENKINS, M.K., TAYLOR, P.S., NORTON, S.D. and URDAHL, K.B., CD28 delivers a co-stimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol., 147, 2461-2466 (1991).
17. LEDERMAN, S., YELLIN, M.J., CLEARY, A.M., PERNIS, A., INGHIRAMI, G., COHN, L.E., COVEY, L.R., LEE, J.J., ROTHMAN, P. and CHESS, L., T-BAM/CD40-L on helper T lymphocytes augments lymphokineinduced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol., 152, 2163-2171 (1994).
18. LINSLEY, P.S., BRADY, W., URNES, M., GROSMAIRE, L.S., DAMLE, N.K. and LEDBETTER, J.A., Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. exp. Med., 173, 721-730 (1991a).
19. LINSLEY, P.S., BRADY, W., URNES, M., GROSMAIRE, L.S., DAMLE, N.K. and LEDBETTER, J.A., CTLA-4 is a second receptor for the B cell activation antigen B7. J. exp. Med., 174, 561-569 (1991b).
20. LU, C. and KERBEL, R.S., Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 120, 1281-1288 (1993).
21. NISHIOKA, Y. and LIPSKY, P.E., The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol., 153, 1027-1036 (1994).
22. NOELLE, R.J., LEDBETTER, J.A. and ARUFFO, A., CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today, 13, 431-433 (1992).
23. PLATSOUCAS, C.D., Human autologous tumor-specific T cells in malignant melanoma. Cancer Metastasis Rev., 10, 151-176 (1991).
24. SMITH, C.A., FARRAH, T. and GOODWIN, R.G., The TNF receptor superfamily of cellular and viral proteins: activation, co-stimulation, and death. Cell, 76, 959-962 (1994).
25. STAMENKOVIC, I., CLARK, E.A. and SEED, B., A B-lymphocyte activated molecule related to the nerve growth factor receptor and induced by cytokines in carcinoma. EMBO J., 8, 1403-1410 (1989).
26. YELLIN, M.J., SINNING, J., COVEY, L.R., SHERMAN, W., LEE, J.J., GLICKMAN-NIR, E., SIPPEL, K.C., ROGERS, J., CLEARY, A.M., PARKER, M., CHESS, L. and LEDERMAN, S., T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their co-stimulatory activity. J. Immunol., 153, 666-674 (1994).